American Capital Advisory’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.28K Buy
86
+12
+16% +$968 ﹤0.01% 393
2026
Q1
$5.23K Sell
74
-1
-1% -$75 ﹤0.01% 395
2025
Q4
$5.92K Buy
75
+4
+6% +$317 ﹤0.01% 362
2025
Q3
$5.85K Sell
71
-7
-9% -$551 ﹤0.01% 348
2025
Q2
$6.27K Buy
78
+17
+28% +$1.31K ﹤0.01% 325
2025
Q1
$4.9K Hold
61
﹤0.01% 339
2024
Q4
$5K Hold
61
﹤0.01% 348
2024
Q3
$5.03K Sell
61
-8
-12% -$598 ﹤0.01% 350
2024
Q2
$4.56K Buy
69
+8
+13% +$571 ﹤0.01% 311
2024
Q1
$3.54K Sell
61
-8
-12% -$558 ﹤0.01% 331
2023
Q4
$4.56K Buy
+69
New +$4.32K ﹤0.01% 311

Other funds holding MET

American Capital Advisory's MET Position: Q2 2026 in Review

American Capital Advisory increased its MetLife (MET) stake by 16% in Q2 2026, buying an estimated $968 and bringing the position to 86 shares worth $7.28K. The position accounts for ﹤0.01% of the portfolio, ranked #393.

American Capital Advisory first reported a position in MET in Q4 2023 and has held it in 11 quarters since. 1,446 funds tracked by Wall St. Rank hold MET as of Q2 2026.

  • American Capital Advisory held 86 shares of MetLife worth $7.28K as of Q2 2026.
  • American Capital Advisory bought 12 MetLife shares in Q2 2026, an estimated $968.
  • MetLife made up ﹤0.01% of American Capital Advisory's portfolio in Q2 2026, its #393 holding.
  • American Capital Advisory first reported a position in MetLife in Q4 2023 and has held it in 11 quarters since.
  • 1,446 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on American Capital Advisory's 13F filing for Q2 2026, filed 28 Jul 2026.